Healthcare

>

Drug Manufacturers—Specialty & Generic

>

OTC:
CTABF

CANNTAB THERAPEUTICS LTD

Recent publications about $CTABF

Canntab Corporate Update

TORONTO, June 30, 2022 /PRNewswire/ – Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the “Company” or “Canntab“) a leading innovator in cannabinoid and

CANNTAB ANNOUNCES CHANGE OF AUDITOR

canntab announces change of auditor canntab announces change of auditor canada newswire toronto may 30 2022 toronto may 30 2022 cnw canntab therapeutics limited cse

CANNTAB ANNOUNCES CHANGE OF AUDITOR

canntab announces change of auditor canntab announces change of auditor pr newswire toronto may 30 2022 toronto may 30 2022 prnewswire canntab therapeutics limited cse

CANNTAB ANNOUNCES CHANGE OF AUDITOR

TORONTO, May 30, 2022 /PRNewswire/ – Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the “Company” or “Canntab“) a leading innovator in cannabinoid and

Register by Email

or
Already a member? Sign In